Oxidation of extracellular matrix modulates susceptibility to degradation by the mesangial matrix metalloproteinase-2

Free Radical Biology and Medicine

Volumn 27, Issue 3-4, 1999, Pages 315-321

  Mattana, Joseph ^a,b   Margiloff, Linda ^a,b   Chaplia, Larissa ^a,b  

^a LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^b Long Isl Camp Albert Einstein C   (United States)

Author keywords

Extracellular matrix; Free radicals; Glomerular mesangium; Metalloproteinases; Oxygen radicals; Protein oxidation

Indexed keywords

ASCORBIC ACID; EDETIC ACID; FERRIC CHLORIDE; GELATIN; GELATINASE A; N TERT BUTYL ALPHA PHENYLNITRONE; RADICAL; SCLEROPROTEIN;

AGING; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME SUBSTRATE; EXTRACELLULAR MATRIX; GLOMERULOSCLEROSIS; KIDNEY INJURY; MESANGIUM; MOUSE; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN MODIFICATION; ZYMOGRAPHY;

ANALYSIS OF VARIANCE; ANIMALS; CARBONIC ACID; CELLS, CULTURED; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; GLOMERULAR MESANGIUM; HYDROLYSIS; KETONES; MATRIX METALLOPROTEINASE 2; MICE; OXIDATION-REDUCTION; SPIN TRAPPING;

EID: 0032856856     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(99)00048-9     Document Type: Article

References (35)

1. Diamond J.R. The role of reactive oxygen species in animal models of glomerular disease. Am. J. Kidney Dis. 19:1992;292-300.
2. Shah S.V. Evidence suggesting a role for hydroxyl radical in passive Heymann nephritis in rats. Am. J. Physiol. 254:1988;F337-F344.
3. Rahman M.A., Emancipator S.S., Seder J.R. Hydroxyl radical scavengers ameliorate proteinuria in rat immune complex glomerulonephritis. J. Lab. Clin. Med. 112:1988;619-626.
4. Baud L., Ardaillou R. Reactive oxygen species production and role in the kidney . Am. J. Physiol. 251:1986;F765-F776.
5. Neale T.J., Ojha P.P., Exner M., Poczewski H., Rüger B., Witzum J.J., Davis P., Kerjaschki D. Proteinuria in passive Heymann nephritis is associated with lipid peroxidation and formation of adducts of type IV collagen. J. Clin. Invest. 94:1994;1577-1584.
6. Thakur V., Walker P.D., Shah S.V. Evidence suggesting a role for hydroxyl radical in puromycin aminonucleoside-induced proteinuria. Kidney Int. 34:1988;494-499.
7. Satriano J.A., Shuldiner M., Hora K., Xing Y., Shan Z., Schlondorff D. Oxygen radicals as second messengers for expression of the monocyte chemoattractant protein, JE/MCP-1, and the monocyte colony stimulating factor, CSF-1, in response to tumor necrosis factor-α and immunoglobulin. J. Clin. Invest. 92:1993;1564-1571.
8. Oberle G.P., Niemeyer J., Thaiss F., Schoeppe W., Stahl R.A.K. Increased oxygen radical and eicosanoid formation in immune-mediated mesangial cell injury. Kidney Int. 42:1992;69-74.
9. Berlett B.S., Stadtman E.R. Protein oxidation in aging, disease and oxidative stress. J. Biol. Chem. 272:1997;20313-20316.
10. Stadtman E.R. Protein oxidation and aging. Science. 257:1992;1220-1224.
11. Liu Y., Rosenthal R.E., Starke-Reed P., Fiskum G. Inhibition of postcardiac arrest brain protein oxidation by acetyl-l-carnitine. Free Radic. Biol. Med. 15:1993;667-670.
12. Carney J.M., Starke-Reed P.E., Oliver C.N., Landum R.W., Cheng M.S., Wu J.F., Floyd R.A. Reversal of age-related increase in brain protein oxidation, decrease in enzyme activity, and loss in temporal and spatial memory by chronic administration of the spin-trapping compound N-tert-butyl-α-phenylnitrone. Proc. Natl. Acad. Sci. USA. 88:1991;3633-3636.
13. Oliver C.N. Inactivation of enzymes and oxidative modification of proteins by stimulated neutrophils. Arch. Biochem. Biophys. 253:1987;62-72.
14. Fucci L., Oliver C.N., Coon M.J., Stadtman E.R. Inactivation of key metabolic enzymes by mixed-function oxidation reactions possible implications in protein turnover and aging . Proc. Natl. Acad. Sci. USA. 80:1983;1521-1525.
15. Oliver C.N., Starke-Reed P.E., Stadtman E.R., Liu G.J., Carney J.M., Floyd R.A. Oxidative damage to brain proteins, loss of glutamine synthetase activity and production of free radicals during ischemia/reperfusion injury to gerbil brain. Proc. Natl. Acad. Sci. USA. 87:1990;5144-5147.
16. Grune T., Reinheckel T., Joshi M., Davies K.J.A. Proteolysis in cultured liver epithelial cells during oxidative stress. J. Biol. Chem. 270:1995;2344-2351.
17. Friguet B., Szweda L.I., Stadtman E.R. Susceptibility of glucose-6-phosphate dehydrogenase modified by 4-hydroxy-2-nonenal and metal-catalyzed oxidation to proteolysis by the multicatalytic protease. Arch. Biochem. Biophys. 311:1994;168-173.
18. Mattana J., Margiloff L., Singhal P.C. Oxidation of mesangial ECM using a mixed function oxidase system augments adhesion of macrophages possible role of macrophage scavenger receptors . Biochem. Biophys. Res. Commun. 212:1995;63-69.
19. Mattana J., Margiloff L., Singhal P.C. Metal-catalyzed oxidation of ECM proteins disrupts integrin-mediated adhesion of mesangial cells. Biochem. Biophys. Res. Commun. 233:1997;50-55.
20. Rupprecht H.D., Schocklmann H.O., Sterzel R.B. Cell-matrix interactions in the glomerular mesangium. Kidney Int. 49:1996;1575-1582.
21. Mattana J., Margiloff L., Sharma P., Singhal P.C. Oxidation of the mesangial matrix metalloproteinase-2 impairs gelatinolytic activity. Inflammation. 22:1998;269-276.
22. Sagar S., Sorbi D., Arbeit L.A., Singhal P.C. Morphine modulates 72-kDA metalloproteinase. Am. J. Physiol. 267:1994;F654-F659.
23. Levine R.L., Garland D., Oliver C.N., Amici A., Climent I., Lenz A.-G., Ahn B.-W., Shaltiel S., Stadtman E.R. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol. 186:1990;464-478.
24. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
25. Oliver C.N., Ahn B., Moerman E.J., Goldstein S., Stadtmanm E.R. Age-related changes in oxidized proteins. J. Biol. Chem. 262:1987;5488-5491.
26. Lunec J., Blake D.R., McCleary S.J., Brailsford S., Bacon P.A. Self-perpetuating mechanisms of immunoglobulin G aggregation in rheumatoid inflammation. J. Clin. Invest. 76:1985;2084-2090.
27. Witzum J.L., Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J. Clin. Invest. 88:1991;1785-1792.
28. Newman S.L., Tucci M.A. Regulation of human monocyte/macrophage function by extracellular matrix. J. Clin. Invest. 86:1990;703-714.
29. Mark K.V.D., Mark H.V.D., Goodman S. Cellular response to extracellular matrix. Kidney Int. 41:1992;632-640.
30. Raghow R. The role of extracellular matrix in postinflammatory wound healing and fibrosis. FASEB J. 8:1994;823-831.
31. Madri J.A., Marx M. Matrix composition, organization and soluble factors: modulators of microvascular cell differentiation in vitro. Kidney Int. 41:1992;560-565.
32. Grune T., Reinheckel T., Davies K.J. A Degradation of oxidized proteins in mammalian cells. FASEB J. 11:1997;526-534.
33. Coux O., Tanaka K., Goldberg A.L. Structure and functions of the 20S and 26S proteasomes. Annu. Rev. Biochem. 65:1996;801-847.
34. Bolton W.K., Benton F.R., Maclay J.G., Surgnill B.C. Spontaneous glomerular sclerosis in aging Sprague-Dawley rats. Am. J. Pathol. 85:1976;277-302.
35. Kaplan C. Age related incidence of sclerotic glomeruli in human kidneys. Am. J. Pathol. 80:1975;227-234.